tradingkey.logo
tradingkey.logo
Search

Ovid Therapeutics Inc

OVID
Add to Watchlist
2.220USD
-0.150-6.33%
Close 07-31 16:00ETQuotes delayed by 15 min
414.34MMarket Cap
LossP/E TTM

OVID Financials

See Ovid Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Ovid Therapeutics Inc Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-0.12/-0.12
Revenue / Forecast
0.00/32.50K
Period
FY2025 Earnings
Revenue(YoY)
7.25M
1181.27%
EPS(YoY)
-0.24
36.65%
Analyst Rating
STRONG BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
13.40%-0.12
190.80%0.12
13.36%-0.17
-154.82%-0.07
12.88%-0.14
39.88%-0.13
-23.84%-0.20
168.30%0.12
12.72%-0.17
-32.77%-0.22
---0.16
---0.18
---0.19
---0.16
---0.61
----
----
----
----
----
Revenue
-100.00%0.00
844.74%718.00K
-23.70%132.00K
3611.24%6.27M
-12.16%130.00K
-46.31%76.00K
58.76%173.00K
125.33%169.00K
123.70%148.00K
205.88%141.56K
881.55%108.97K
--75.00K
-95.42%66.16K
--46.28K
--11.10K
--0.00
-99.31%1.45M
-100.00%0.00
-100.00%0.00
--0.00
Net Profit
-65.98%-16.99M
204.43%9.66M
13.19%-12.16M
-154.97%-4.68M
12.48%-10.23M
39.61%-9.25M
-24.47%-14.01M
168.67%8.52M
12.45%-11.69M
-33.18%-15.32M
5.98%-11.25M
14.94%-12.41M
17.08%-13.36M
54.26%-11.50M
-5.13%-11.97M
7.60%-14.59M
-109.56%-16.11M
-14.17%-25.15M
30.69%-11.38M
29.99%-15.79M
Net Margin
----
111.05%1345.82%
-13.77%-9210.61%
-101.48%-74.68%
0.36%-7873.08%
-12.49%-12175.00%
21.60%-8095.95%
130.48%5042.01%
60.86%-7901.35%
56.46%-10823.47%
---10325.94%
---16544.44%
---20187.74%
---24859.09%
---2929.29%
----
----
----
----
----
Gross Margin
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
Revenue
-100.00%0.00
844.74%718.00K
-23.70%132.00K
3611.24%6.27M
-12.16%130.00K
-46.31%76.00K
58.76%173.00K
125.33%169.00K
123.70%148.00K
205.88%141.56K
881.55%108.97K
--75.00K
-95.42%66.16K
--46.28K
--11.10K
--0.00
-99.31%1.45M
-100.00%0.00
-100.00%0.00
--0.00
Operating profit
-42.20%-17.85M
-14.65%-12.29M
5.32%-12.52M
75.27%-5.07M
27.94%-12.55M
41.05%-10.72M
-9.95%-13.23M
-44.77%-20.52M
-16.95%-17.42M
-49.42%-18.19M
6.05%-12.03M
0.92%-14.17M
8.45%-14.89M
53.81%-12.17M
-9.61%-12.80M
0.06%-14.30M
-109.21%-16.27M
-22.06%-26.35M
28.79%-11.68M
38.15%-14.31M
Net Profit
-65.98%-16.99M
204.43%9.66M
13.19%-12.16M
-154.97%-4.68M
12.48%-10.23M
39.61%-9.25M
-24.47%-14.01M
168.67%8.52M
12.45%-11.69M
-33.18%-15.32M
5.98%-11.25M
14.94%-12.41M
17.08%-13.36M
54.26%-11.50M
-5.13%-11.97M
7.60%-14.59M
-109.56%-16.11M
-14.17%-25.15M
30.69%-11.38M
29.99%-15.79M
Current assets
248.74%160.15M
32.94%74.37M
-56.21%28.82M
-47.97%42.09M
-50.71%45.92M
-48.96%55.94M
-28.23%65.83M
-20.83%80.89M
-22.05%93.17M
-16.58%109.60M
-34.72%91.71M
-34.54%102.17M
-29.73%119.52M
-31.03%131.38M
-31.48%140.50M
-27.70%156.08M
-28.13%170.09M
154.50%190.48M
126.97%205.06M
389.39%215.87M
Total current liabilities
69.21%15.75M
-21.23%8.29M
-41.56%6.80M
-36.79%8.92M
4.54%9.31M
-8.30%10.52M
34.24%11.63M
39.22%14.12M
32.47%8.90M
64.12%11.47M
28.68%8.66M
10.05%10.14M
-34.29%6.72M
-52.75%6.99M
-33.11%6.73M
-18.37%9.22M
-37.43%10.23M
-32.93%14.80M
-43.96%10.06M
-22.60%11.29M
Total assets
176.32%225.63M
63.76%150.93M
-37.80%63.85M
-34.43%77.43M
-37.96%81.65M
-36.01%92.17M
-17.90%102.65M
-13.31%118.09M
-8.20%131.61M
-7.24%144.03M
-24.24%125.03M
-23.18%136.23M
-24.98%143.37M
-20.19%155.27M
-20.31%165.03M
-18.66%177.33M
-19.52%191.10M
156.23%194.54M
126.08%207.09M
380.65%218.00M
Total liabilities
22.26%27.36M
-15.32%20.27M
-27.36%19.15M
-25.87%21.64M
-58.04%22.38M
-57.42%23.94M
11.07%26.36M
14.33%29.19M
137.89%53.33M
144.55%56.23M
3.29%23.74M
1.38%25.53M
-14.10%22.42M
55.38%22.99M
128.34%22.98M
123.05%25.18M
59.67%26.10M
-54.18%14.80M
-64.00%10.06M
-24.09%11.29M
Total equity
234.48%198.27M
91.51%130.66M
-41.41%44.70M
-37.25%55.79M
-24.28%59.28M
-22.29%68.23M
-24.68%76.29M
-19.69%88.90M
-35.28%78.28M
-33.62%87.80M
-28.69%101.29M
-27.24%110.70M
-26.70%120.95M
-26.41%132.27M
-27.90%142.05M
-26.40%152.15M
-25.38%165.00M
311.96%179.75M
209.57%197.02M
578.12%206.71M
Net operating income
-35.20%-13.90M
-4.00%-10.41M
14.23%-12.87M
66.51%-4.77M
38.39%-10.28M
15.99%-10.01M
-49.31%-15.01M
-21.79%-14.26M
-37.75%-16.68M
-29.82%-11.91M
20.71%-10.05M
11.91%-11.71M
39.70%-12.11M
23.53%-9.18M
-16.60%-12.68M
31.56%-13.29M
-112.48%-20.09M
17.31%-12.00M
-639.88%-10.87M
-12.93%-19.42M
Net investment
16.62%5.95M
-438.45%-72.06M
1630.48%5.05M
-6.00%12.05M
-74.73%5.10M
143.89%21.29M
106.70%292.00K
-36.10%12.82M
-33.22%20.19M
-1063.59%-48.52M
-122.38%-4.36M
124.87%20.07M
2908.94%30.23M
-2474.44%-4.17M
-2961.38%-1.96M
-4993.60%-80.68M
-9246.58%-1.08M
-79.00%-161.96K
-67.17%-64.03K
-105.12%-1.58M
Net financing
684376.92%88.98M
--75.18M
-60.53%15.00K
-100.00%0.00
-94.30%13.00K
-100.00%0.00
-83.01%38.00K
68.64%356.00K
240.33%228.00K
68985.51%30.03M
174.07%223.72K
92.70%211.10K
102.52%66.99K
-139.93%-43.60K
-85.13%81.63K
-5.71%109.55K
-74.49%33.08K
146.96%109.18K
-98.83%549.05K
-31.38%116.19K

FAQs

What is the total revenue of Ovid Therapeutics Inc?

According to Ovid Therapeutics Inc's FY2025 earnings report, its total revenue reached 7.25M, with a year-on-year change of 566.00K.

What are the current assets of Ovid Therapeutics Inc?

According to Ovid Therapeutics Inc's FY2025 earnings report, its current assets were 74.37M, with a year-on-year change of 32.94.

What are the total assets of Ovid Therapeutics Inc?

According to Ovid Therapeutics Inc's FY2025 earnings report, its total assets of Ovid Therapeutics Inc were 150.93M, with a year-on-year change of 63.76.

What are the total liabilities of Ovid Therapeutics Inc?

According to Ovid Therapeutics Inc's FY2025 earnings report, its total liabilities of Ovid Therapeutics Inc were 20.27M, with a year-on-year change of -15.32.

What is the total equity of Ovid Therapeutics Inc?

According to Ovid Therapeutics Inc's FY2025 earnings report, its total equity of Ovid Therapeutics Inc was 130.66M, with a year-on-year change of 91.51.

What is the net operating income of Ovid Therapeutics Inc?

According to Ovid Therapeutics Inc's FY2025 earnings report, its net operating income of Ovid Therapeutics Inc was -42.44M, with a year-on-year change of 31.42.

What is the net investment of Ovid Therapeutics Inc?

According to Ovid Therapeutics Inc's FY2025 earnings report, its net investment of Ovid Therapeutics Inc was -49.85M, with a year-on-year change of -191.32.

What is the net financing of Ovid Therapeutics Inc?

According to Ovid Therapeutics Inc's FY2025 earnings report, its net financing of Ovid Therapeutics Inc was 75.21M, with a year-on-year change of 11991.16.

What is the Earnings Per Share (EPS) of Ovid Therapeutics Inc?

According to Ovid Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.24, with a year-on-year change of 36.65.

What is the net income of Ovid Therapeutics Inc?

According to Ovid Therapeutics Inc's FY2025 earnings report, its net income was -17.41M, with a year-on-year change of 34.12.

What is the net margin of Ovid Therapeutics Inc?

According to Ovid Therapeutics Inc's FY2025 earnings report, its net profit margin was -240.13, with a year-on-year change of 94.86.

What is the Return on Equity (ROE) of Ovid Therapeutics Inc?

According to Ovid Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -17.51, with a year-on-year change of 48.32.

What is the Return on Assets (ROA) of Ovid Therapeutics Inc?

According to Ovid Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -14.33, with a year-on-year change of 35.99.

What is the operating profit of Ovid Therapeutics Inc?

According to Ovid Therapeutics Inc's FY2025 earnings report, its operating profit was -42.44M, with a year-on-year change of 31.42.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.